Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbingdon Healt. Regulatory News (ABDX)

Share Price Information for Abingdon Healt. (ABDX)

Share Price is delayed by 15 minutes
Get Live Data
12.75    0.50 (4.08%)
Bid:
12.50
Ask:
13.00
Spread: 0.50 (4.00%)
Market Cap: £32.01m
ABDX Live PriceLast checked at - London Stock Exchange

Intraday Abingdon Healt. Share Chart

Directorate Change

19 Dec 2024 07:00

RNS Number : 6515Q
Abingdon Health PLC
19 December 2024
 

 

Abingdon Health plc

("Abingdon Health", the "Group" or the "Company")

 

Directorate Change

Appointment of Chief Financial Officer

 

York, U.K. 19 December 2024: Abingdon Health plc (AIM: ABDX), a leading international lateral flow contract research (CRO) and contract development and manufacturing organisation (CDMO), announces the appointment of Tom Hayes as Chief Financial Officer ("CFO") and a Director of the Company. Tom will join Abingdon on 6 January 2025 on a part-time basis and will assume the full-time position by April 2025.

 

Tom has significant capital markets experience having spent the last ten years as Group Finance Director at Northern Bear plc, an AIM-listed Group of ten specialist building services companies assembled through an acquisition strategy. Tom has previously held roles at Sentio Insight LLP, a boutique advisory firm, providing a range of financial due diligence and transaction services, and Ernst & Young LLP, gaining corporate finance advisory experience in the private equity, corporate and public sectors. Tom qualified as a Chartered Accountant with Arthur Andersen & Co.

 

Tom Hayes

Chief Financial Officer of Abingdon Health plc

 

Dr Chris Hand, Executive Chairman of Abingdon Health plc, commented: "I am delighted to welcome Tom to Abingdon Health plc as CFO and board director. This is a key time for Tom to join as we continue our growth, consolidate our recent acquisitions and expand our activities into the USA via our Madison, WI base. Tom has over 25 years' experience, particularly with AIM-listed companies, having worked as Group Finance Director at Northern Bear plc and prior to this in advisory roles. 2025 is going to be an exciting year for Abingdon with our upcoming growth plans and Tom with his expertise will be a great addition to the business."

 

Additional Disclosures Required under the AIM Rules for Companies

Thomas Edward Hayes (aged 48) has held the following directorship or partnerships in the past five years:

 

Current directorships/partnerships

Springs Roofing Limited

Alcor Handling Solutions Limited

H. Peel & Sons Limited

J Lister Electrical Limited

Isoler Limited

Jennings Roofing Limited

Previous directorships/partnerships (last five years)

Sab Invest LLP (Dissolved)

Lister Holdings (York) Limited (Dissolved)

Jennings Properties Limited (Dissolved)

H Peel & Sons (Holdings) Limited (Dissolved)

Maxaim Strategic and Financial Management Limited (Dissolved)

Arcas Building Solutions Limited

Northern Bear (Safety) Limited

Wensley Roofing Limited

MGM Limited

Northern Bear plc

SH Consultancy Oakwood Limited

Sentio Insight LLP

A1 Industrial Trucks Limited

System Roofing Services Limited

Northern Bear Construction Limited

Northern Bear Roofing Limited

Joom LLP

 

Tom Hayes and persons closely associated (as defined under MAR) with Mr Hayes do not hold any shares in the Company.

 

Save as disclosed above, there is no further information to be disclosed in respect of the above appointment pursuant to Rule 17 and Schedule 2 paragraph (g) of the AIM Rules for Companies.

 

Enquiries:

 

Abingdon Health plc

www.abingdonhealth.com/investors/

Chris Yates, Chief Executive Officer

Via Walbrook PR

Chris Hand, Executive Chairman

Zeus (Sole Broker and Nominated Adviser)

Tel: +44 (0)20 3829 5000

Chris Fielding / Alexandra Campbell-Harris (Corporate Finance)

Fraser Marshall (Corporate Broking)

 

Walbrook PR (Media & Investor Relations)

Tel: +44 (0)20 7933 8780 or abingdon@walbrookpr.com

Paul McManus / Alice Woodings

Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654

Phillip Marriage

+44 (0)7867 984 082

 

 

About Abingdon Health plc

Abingdon Health Group is a leading med-tech contract service provider offering its services to an international customer base.

 

The Company's CDMO division offers lateral flow product development, regulatory support, technology transfer and manufacturing services for customers looking to develop new assays or transfer existing laboratory-based assays to a lateral flow format. Abingdon Health's CDMO division has the internal capabilities to take lateral flow projects, in areas such as infectious disease and clinical testing, including companion diagnostics, animal health and environmental testing, from initial concept through to routine and large-scale manufacturing; from "idea to commercial success".

 

Abingdon's regulatory services companies, Compliance Solutions (Life Sciences) and IVDeology, provide a broad range of regulatory services to the in vitro diagnostic and wider medical device industry, to support customers in bringing products to market across a range of territories including the USA, EU and the UK. Our consultancy services range from design, implementation and maintenance of quality management systems, preparation of technical files for regulatory approvals, part-time and interim management support, auditing both internal and external, management reviews and presentations, training and mentoring.

 

Abingdon Health's Abingdon Simply Test range of self-tests is an e-commerce platform that offers a range of self-tests to empowers consumers to manage their own health and wellbeing. The Abingdon Simply Test e-commerce site offers consumers a range of information to support them in making informed decisions on the tests available. In addition, the site provides Abingdon's contract services customers with a potential route to market for self-tests. The Abingdon Simply Test range is also sold through international distributors and through other channels in the UK and Ireland, such as pharmacy chains.

 

Founded in 2008, Abingdon Health is headquartered in York, England.

 

For more information visit: www.abingdonhealth.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAMZMMZNRDGDZM
Date   Source Headline
29th May 20267:00 amRNS-RPresentation at Mello2026
27th May 20267:00 amRNSUS tax credit agreement
19th May 20267:00 amRNSEarn-out Consideration and Issue of Equity
11th May 20267:00 amRNS-RLaunch of LVOne Stroke Test by UpFront Diagnostics
7th May 20265:38 pmRNSHolding(s) in Company
6th May 20267:00 amRNS-RUpdate on Partnership with 4TEEN4 Pharmaceuticals
21st Apr 20267:00 amRNSAdmission to trading on OTCQB in the US
15th Apr 20267:00 amRNSEMI Share Option Scheme
14th Apr 20267:00 amRNSTrading to commence on the OTCQB in the US
30th Mar 20267:00 amRNS£4.8m contracts awarded
17th Mar 20267:00 amRNSHalf-year Financial Report
17th Mar 20267:00 amRNSHalf-year Financial Report
12th Mar 20267:00 amRNS$2.5m Contract for clinical self-test development
10th Mar 20267:00 amRNSTrading on the OTCQB Venture Market in the US
5th Mar 20267:00 amRNSNotice of Results
15th Jan 20267:01 amRNSTrading Update
15th Jan 20267:00 amRNSAppointment of NOMAD & Corporate Broker
29th Dec 20252:35 pmRNSExercise of options and total voting rights
29th Dec 20252:35 pmRNSExercise of options and total voting rights
18th Dec 20257:00 amRNS-REuropean patent for AppDx® smartphone reader
10th Dec 20251:47 pmRNSResult of Annual General Meeting
4th Dec 20257:00 amRNSVesting and Award of Options under LTIP
2nd Dec 20253:08 pmRNSHolding(s) in Company
14th Nov 20252:00 pmRNSNotice of AGM & Publication of 2025 Annual Report
11th Nov 20257:00 amRNSFinal Results
10th Nov 20257:00 amRNSc.US$2m multiplex diagnostic test contract win
6th Nov 20257:00 amRNSLaunch of seaweed-based lateral flow housings
4th Nov 20254:58 pmRNSHolding(s) in Company
4th Nov 20257:00 amRNSHolding(s) in Company
3rd Nov 20257:00 amRNSNotice of Results
30th Oct 20259:43 amRNSResult of Meeting and TVR
17th Oct 20257:00 amRNSResult of Retail Offer
14th Oct 20257:58 amRNSLaunch of Retail Offer
14th Oct 20257:47 amRNSResult of Placing and Notice of GM
13th Oct 20255:04 pmRNSProposed Placing and Retail Offer
1st Sep 20257:00 amRNSUS CDMO Operations Update
14th Aug 20256:01 pmRNSDirector/PDMR Shareholding
5th Aug 20257:00 amRNSTrading update
31st Jul 20257:00 amRNSc. US$2.5m companion diagnostic test contract win
12th Jun 20257:00 amRNS€2m contract win for companion diagnostic test
4th Jun 20257:00 amRNS-RUpdate re. strategic partnership with FOFH
2nd Jun 20257:00 amRNS-RAvian flu (H5N1) lateral flow test
2nd May 202512:00 pmRNSAward of Options under LTIP
24th Mar 20257:00 amRNSDirectorate Changes
24th Mar 20257:00 amRNSHalf-year Report
17th Mar 20257:00 amRNSNotice of Results
17th Mar 20257:00 amRNSSalistick™ to be launched in Germany
27th Jan 20257:00 amRNSFunding award to develop test for malaria parasite
19th Dec 20247:00 amRNSDirectorate Change
17th Dec 20247:09 amRNSAbingdon Analytical Laboratory opens at Doncaster

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.